Retractable Technologies Inc (RVP)
1.07
+0.01
(+0.94%)
USD |
NYAM |
Apr 26, 16:00
1.07
0.00 (0.00%)
After-Hours: 16:34
Retractable Technologies Research and Development Expense (Quarterly): 0.1617M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1617M |
| September 30, 2023 | 0.151M |
| June 30, 2023 | 0.1388M |
| March 31, 2023 | 0.1298M |
| December 31, 2022 | 0.1181M |
| September 30, 2022 | 0.1057M |
| June 30, 2022 | 0.2064M |
| March 31, 2022 | 0.0955M |
| December 31, 2021 | 0.1539M |
| September 30, 2021 | 0.1992M |
| June 30, 2021 | 0.399M |
| March 31, 2021 | 0.1493M |
| December 31, 2020 | 0.1752M |
| September 30, 2020 | 0.1346M |
| June 30, 2020 | 0.1263M |
| March 31, 2020 | 0.1385M |
| December 31, 2019 | 0.1382M |
| September 30, 2019 | 0.1349M |
| June 30, 2019 | 0.1155M |
| March 31, 2019 | 0.1275M |
| December 31, 2018 | 0.1892M |
| September 30, 2018 | 0.1465M |
| June 30, 2018 | 0.1415M |
| March 31, 2018 | 0.1442M |
| December 31, 2017 | 0.2748M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1599M |
| June 30, 2017 | 0.1574M |
| March 31, 2017 | 0.1484M |
| December 31, 2016 | 0.1821M |
| September 30, 2016 | 0.1179M |
| June 30, 2016 | 0.1469M |
| March 31, 2016 | 0.1249M |
| December 31, 2015 | 0.1978M |
| September 30, 2015 | 0.1258M |
| June 30, 2015 | 0.1677M |
| March 31, 2015 | 0.1163M |
| December 31, 2014 | 0.1106M |
| September 30, 2014 | 0.1292M |
| June 30, 2014 | 0.1922M |
| March 31, 2014 | 0.1847M |
| December 31, 2013 | 0.1888M |
| September 30, 2013 | 0.268M |
| June 30, 2013 | 0.1994M |
| March 31, 2013 | 0.1808M |
| December 31, 2012 | 0.2708M |
| September 30, 2012 | 0.244M |
| June 30, 2012 | 0.1655M |
| March 31, 2012 | 0.1915M |
| December 31, 2011 | 0.2759M |
| September 30, 2011 | 0.1693M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.0955M
Minimum
Mar 2022
0.399M
Maximum
Jun 2021
0.1564M
Average
0.1385M
Median
Mar 2020
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.08M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |